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Abstract The 5'-untranslated region (5'-UTR) sequences of 33 
GB virus C/hepatitis G virus (GBV-C/HGV) obtained from 
different geographic areas were determined through reverse-
transcription polymerase chain reaction and dideoxy chain 
termination sequencing, the alignment of sequences, the estima-
tion of the number of nucleotide substitution per site, and 
construction of phylogenetic trees. The 5'-UTR of GBV-HGV 
was found to be heterogeneous, with 70.9-99.5% homology. 
Three distinct phylogenetic branches were observed consistently 
in all phylogenetic trees. GBV-C is the prototype for one, HGV 
for another, and there is a new branch which consisted of GBV-
C/HGV isolates from Asia. Genotype-specific restriction sites 
for the restriction enzymes, ScrFI and BsmFI, were identified, 
and a simple restriction fragment polymorphism analysis was 
developed for genotyping. These data provide evidence that 
GBV-C/HGV consists of three different genotypes. Our simple 
genotyping assay will also provide a tool for epidemiological 
studies of GBV-C/HGV infection. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Recently, two research groups independently discovered a 
new virus associated with non-A-E hepatitis which they 
named as GB virus C (GBV-C) [1] and hepatitis G virus 
(HGV) [2]. Studies in blood product recipients have demon-
strated the transmissibility of GBV-C/HGV [2]. Based on clin-
ical and epidemiological profiles, these viruses are believed to 
be transmitted through parenteral route, including blood and 
its transfusion products, and sharing of needles among intra-
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venous drug users [3,4]. Comparison of the nucleotide and the 
deduced amino acid sequences showed good homology be-
tween these viruses. In addition, the putative genomic organ-
ization also appears to be similar. Hence, they are probably 
isolates from the same group of viruses. For simplicity, they 
are referred to as GBV-C/HGV in this paper, as proposed by 
Dr. Zuckerman [5]. 
The presence of a G D D domain in the putative NS5B re-
gion, together with the similar genomic organization of this 
putative gene and other fiaviviruses, suggests that the GBV-C/ 
H G V NS5B gene encodes for a RNA-dependent R N A polym-
erase. This type of viral enzyme is known to have no proof-
reading activities during the replication of R N A genome and 
hence, the GBV-C/HGV genome is expected to be heteroge-
neous. Recently researchers from Abbot t reported independ-
ently that the GBV-C/HGV isolates consisted of five geno-
types based on the 5 ' -UTR [6]. However, it is no report on 
GBV-C/HGV genotypmg confirmed with different evolution-
ary strategies and on simple methods for genotypmg of this 
virus. 
In the present study, we have surveyed a large number of 
GBV-C/HGV samples worldwide and identified 33 GBV-C/ 
H G V R N A positive samples. We have sequenced the putative 
5 ' -UTR of these isolates and determined the phylogenetic 
relations between these isolates with three different strategies, 
which suggests the existence of three different genotypes. A 
restriction fragment length polymorphism (RFLP) for the de-
termination of these genotypes was then designed. 
2. Materials and methods 
2.1. Serum samples 
Thirty-three serum samples positive for GBV-C/HGV RNA as de-
termined by our RT-PCR assays based on the 5'-UTR of GBV-C/ 
HGV were available for this study. These serum samples were col-
lected from patients from Cameroon, Israel, Japan, Korea, Mongolia, 
Saudi Arabia and the USA. 
2.2. RNA extraction and CDNA synthesis 
RNA was extracted from 100 (il of serum using a SepaGene-RVR 
(Sanko, Tokyo, Japan). Extracted RNA was precipitated with 200 ul 
of isopropanol at room temperature for 5 min, pelleted down by 
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centrifugation (12000 rpm, for 15 min, at 4°C), washed twice with 
70% (v/v) ethanol, and air-dried. cDNA was then synthesized by in-
cubating in a 25 ui reaction mixture containing the extracted RNA, 
300 ng of random hexamer (Life Technologies, Gibco BRL, Gaithers-
burg, MD), 20 mmol/1 Tris-HCl (pH 8.4), 50 mmol/1 KC1, 2.5 mmol/1 
MgCl2, 200 umol/1 deoxyribonucleotide triphosphate, 3 U/ul RNasin 
(Promega, Madison, WI) and 250 U of Moloney murine leukemia 
virus reverse transcriptase (Life Technologies) and incubated at 
37°C for 60 min. 
2.3. PCR conditions 
One-tenth (2.5 ul) of the synthesized cDNA was added to following 
amplification mixture, 5 ul of lOxAmpliTaq polymerase buffer (100 
mmol/1 Tris-HCl at 8.4, 100 mmol/1 KC1, 15 mmol/1 MgCl2, 0.1% 
gelatin), 2.5 ul of 10 mmol/1 deoxyribonucleotide triphosphate, 0.5 
ul of AmpliTaq Gold (5 U/ul) (Perkin-Elmer Cetus, Norwalk, CT). 
10 pmols of sense primer (5gf2; 5'-GGTTGGTAGGTCG-
TAAATCCCGGTCA-3') and antisense primer (5gf6; 5'-GACATT-
GAAGGGCGACGTRGACCGTAC-3'; where R represent a mixture 
of A and G) in a 50 (il reaction volume. The amplification profile was 
9 min at 96°C, followed by 40 cycles of 94°C for 60 s (denaturation), 
60 s at 55°C (annealing), and 60 s at 72°C (extension), using a 96-well 
cycler (GeneAmp 9600, Perkin-Elmer Cetus). One microliter of the 
first-round PCR product was then added to a second-round PCR 
mixture with the same composition but with the set of inner primers 
(5gf3; sense, TGGTAGCCACTATAGGTGGGT-3'; (5gf4, sense, 5'-
GCGACGTGGACCGTACRTGGGCGT-3'). Five microliters of the 
second-round PCR products was then analyzed by electrophoresis on 
a 3% agarose gels, stained with ethidium bromide, and visualized 
under ultraviolet light. 
The PCR primers were designed based on the most conserved re-
gions derived from the known sequences available in GenBank. These 
primers were confirmed to be specific for GBV-C/HGV through com-
puter search. The primers were prepared with a DNA synthesizer 
(Model 394, Perkin-Elmer Cetus). Standards precautions for avoiding 
contamination for PCR were observed. A negative control serum were 
also included in each run to ensure specificity. 
2.4. Cloning and sequencing of the PCR products 
All the PCR products were cloned into the pGEMT vector (Prom-
ega, Madison, WI). Positive clones were identified, expanded, and 
sequenced bidirectionally using the dideoxynucleotide chain termina-
tion method (Dye Terminator Cycle Sequencing FS Ready Reaction 
Kit, Perkin-Elmer Cetus). The sequences were obtained with a DNA 
sequencer (ABI PRISM 377 DNA Sequencer, Perkin-Elmer Cetus). 
2.5. Molecular evolutionary analysis 
Molecular evolutionary analysis was performed to elucidate the 
molecular evolutionary relationship of the isolates and the previously 
reported GBV-C and HGV strains. The analyses were performed with 
the computer program ODEN version 1.1.1 [7]. The number of nu-
cleotide substitutions per site between all possible pairs of these iso-
lates was estimated by the 6-parameter method [8]. Based on these 
values, phylogenetic trees were constructed by both the unweighed 
pair grouping method with arithmetic means (UPGMA) [9], and the 
neighbor-joining (NJ) methods [10]. For more confirmatory evidence, 
we have also employed the PHYLIP version 3.5 computer program 
[11] to determine the evolutionary distance. With this program, the 
genetic distances between pairs of nucleotide sequences were estimated 
using the DNADIDT program with Maximum Likelihood (ML), and 
the phylogenetic tree was constructed using the programs NEIGH-
BOR and DRAWTREE. 
The statistical reliability of the phylogenetic trees were assessed 
using the bootstrap method by Felsenstein based on 100 replicates 
[12]. 
2.6. RFLP analysis 
RFLP analysis was performed after the genotype-specific restriction 
sites were identified. Restriction digestions were carried out with 10 ul 
of the second PCR products for 3 h after adjustment with 10 X enzyme 
reaction buffer according to the manufacturer's recommendations. 
Reactions were carried out with 10 U of either ScrFI (New England 
BioLabs, MA) at 37°C, or BsmFI (New England BioLabs) at 65°C. 
The digested PCR products were electrophoresed on 3.0%) Nusieve 
GTG (3:1) agarose gel in lXTBE buffer (134 mmol/1-Tris-HCl, 68 
mmol/1 boric acid; 2.5 mmol/1 EDTA) containing 500 ng ethidium 
bromide per milliliter. The RFLP pattern was then evaluated under 
ultraviolet light. 
3. Results 
The nucleotide sequences of 5 ' -UTR obtained from all 33 
isolates were aligned together with GBV-C which was from a 
patients from West Africa (accession N o . U36380), and H G V 
from which was from a US patient (accession N o . U44402). 
Phylogenetic trees were then constructed based on all the 
three well-accepted strategies, U P G M A (Fig. la) , N J (Fig. 
lb) , and P H Y L I P (Fig. lc) methods. Phylogenetic trees of 
5 ' -UTR of GBV-C/HGV genome showed identical phyloge-
netic relationship based on all three methods. In all trees, the 
isolates were segregated clearly into three separate phyloge-
netic branches (or genotypes), which were tentatively named 
as G B type including GBV-C strain, H G type including H G V 
strain, and a new type not reported before. 
With boots t rap analysis for evaluation of the statistical re-
liability of the tree, the cluster of the GB, H G and new types 
had 99%, 95% and 70% of reliability, respectively. 
There was good homology between the isolates within a 
type, 87.4-98.4% for the G B type, 88.0-98.9% for the H G 
type, and 94.0-99.5%) for the new type (Table 1). The homol-
ogy between different types was significantly lower, with 70 .9-
84.1% between GBV and H G types, 83.1-91.3% between 
H G V and the new types, and 79.1-89.0% between the new 
and G B types (Table 1). 
G B type consisted of isolates Af-107, Af-13, Af-26, Af-29, 
Af-33, Af-42, Af-47, Af-53, Af-87, Af-96, Sa-77 and GBV-C 
(Table 1 and Figs. 1 and 2A). These were from patients from 
the African continent (Af for Africa, and Sa for Saudi Ara-
bia). H G type consisted of isolates U S A - r l l , U S A - r l l 9 , Sa-
97, USA-r90, Sa-29, Ja-Sl , U S A - r l 3 1 , USA-r28, Mo-287, Ja-
S7, Ja-S4 and H G V (Table 1 and Figs. 1 and 2B). These 
isolates were from various geographic regions (USA for 
United States of America, M o for Mongolia, Ja for Japan). 
The new type consisted of the isolates Ja-12, Sa-43, Mo-331, 
Ja-KI, Ja-SN, Mo-345, Mo-351, Is-21, Is-28, Mo-186, and 
Kor-63 (Table 1 and Figs. 1 and 2C). These isolates were 
also from patients from various geographic locations (Kor 
for Korea, Is for Israel). 
In order to design a simple genotyping assay, an at tempt 
was made to identify specific restriction sites that are unique 
for each genotypes. Two genotype-specific restriction sequen-
ces (ScrFI and BsmFI) were identified (Fig. 2). Fig. 3 shows 
the restriction digestion pattern and Fig. 4 shows the sche-
matic diagram for the P C R and restriction digestion pattern. 
For the G B type, the specific restriction enzyme sites for ScrFI 
Fig. 1. Phylogenetic trees for the GBV-C/HGV 5'-untranslated region (5'-UTR) as determined by (a) unweighed pair grouping method with 
arithmetic means (UPGMA), (b) neighbor-joining (NJ), and (c) PHYLIP program. Note that the isolates were segregated into the same 
branches based on all three methods. To confirm the statistical reliability of the tree obtained, the bootstrap analysis was performed with the 
method by Felsenstein based on 100 replicates (b). The three major branches had 99%o, 95%o and 70%> reliability, respectively. 
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Fig. 2. A: Alignment of the 5'-UTR sequences of the GB type isolate. These nucleotide sequences were derived from African and Saudi Ara-
bian isolates. B: Alignment of the 5'-UTR sequences of the HG type isolates. These nucleotide sequences were from patients from USA, Saudi 
Arabia, Japan, and Mongolia. C: Alignment of the 5'-UTR sequences of the new type of GBV-C/HGV isolates. These nucleotide sequences 
were from patients from Japan, Saudi Arabia, Mongolia, Israel and Korea. For all figures, the prototypes GBV-C (Accession No. U36380) and 
HGV (Accession No. HGU44402) were also included for comparison. Identical nucleotide are shown as a dot. The consensus nucleotide se-
quences of these isolates for each type are given in the top line. The location of the inner primers are given. The sequences that recognized by 
the restriction enzymes ScrFI and BsmFI are boxed. ▼ : Cutting site of ScrFI, v : Cutting site of BsmFI. Af, Africa; Sa, Saudi Arabia; USA, 
United States; Ja, Japan; Mo, Mongolia; Is, Israel; Kor, Korea. 
were found at positions 268 and 308 and that for BsmFI was 
found at position 184 in the amplified region for all isolates 
within this genotype (Figs. 1-4). For the HG type, some 
strains (e.g., USA-r90, Sa-29, Ja-Sl, USA-rl31, USA-r28, 
Mo-287, Ja-S7, Ja-S4, HGV and GBV-C) had a restriction 
site for ScrFI at position 309 while in other isolates (e.g., 
USA-rll, USA-rll9, Sa-97), this restriction site was absent. 
There was no restriction site for BsmFI in all isolates in the 
HG type (Fig. 2B and Figs. 3 and 4). For the new type, a 
large proportion of the isolates (e.g., Ja-12, Sa-43, Mo-331, 
Ja-KI, Ja-SN, Mo-345, Mo-351, Is-21, Is-28, HGV and GBV-
C) had a restriction site for ScrFI at position 309 in the 
amplified region while in two isolates (Mo-186 and Kor-63), 
this restriction site was absent. However, the BsmFI restric-
tion site was found at position 184 for all isolates of this new 
type (Fig. 2C and Figs. 3 and 4). Hence, the pattern of re-
striction enzyme cutting by ScrFI and BsmFI allowed the 
assignment of specific genotypes in these 33 GBV-C/HGV 
isolates. 
4. Discussion 
This study showed three important points. First, the 5'-
UTR sequence of GBV-C/HGV, though relatively well con-
served, is still heterogeneous. Second, phylogenetic trees 
showed that the isolates clearly segregated into three separate 
branches, suggesting the presence of three different genotypes. 
Third, there are genotype-specific restriction sites that may be 
utilized for the establishment of a simple RFLP-based geno-
typing assay. 
The 5'-UTR sequences for most flaviviruses and pestivi-
ruses, to which GBV-C/HGV is related, are relatively well 
conserved. This is attributed to the fact that this region is 
important for both replication and viral protein translation. 
Recently, an internal ribosomal site [13] has been reported in 
GBV-C. The predicted secondary, as well as the tertiary and 
quarternary structures, are likely to be important for viral 
replication/translation. This poses another constraint to the 
variability of the nucleotide sequence in this region. However, 
despite these constraints, this genomic region is still heteroge-
neous. It is interesting to note that some of the nucleotide 
substitution are constant for some isolates, suggesting that 
these isolates are phylogenetically close to each other. 
This deduction was confirmed by the phylogenetic trees of 
the isolates reported here. The isolates, which were collected 
from six countries in four continents (Africa, America, Eu-
rope, and Asia), were found to form three distinct phyloge-
netic branches. These three major clusters were obtained by 
three different strategies of molecular phylogenetic analysis 
and were confirmed with high reliability by bootstrap analysis. 
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Fig. 3. A: RFLP pattern after ScrFI digestion of the 5'-UTR PCR products, (i) GB type of isolates: lanes 1-11, Af-107, Af-13, Af-26, Af-29, 
Af-33, Af-42, Af-47, Af-53, Af-87, Af-96, Sa-77, respectively, (ii) HG type of isolates: lanes 1-11, USA-rll, USA-rll9, Sa-97, USA-r90, Sa-29, 
Ja-Sl, USA-rl31, USA-r28, Mo-287, Ja-S7, Ja-S4, respectively, (iii) New type of isolates: lanes 1-11, Ja-12, Sa-43, Mo-331, Ja-KI, Ja-SN, Mo-
345, Mo-351, Is-21, Is-28, Mo-186, Kor-63, respectively. B: RFLP pattern after BsmFI digestion of the 5'-UTR PCR products, (i) GB type of 
isolates: same lane order as in (A.i). (ii) HG type of isolates: same lane pattern as in (A.ii). (iii) New type of isolates: same lane pattern as in 
(A.iii). 
Interestingly, it is observed that the distribution of GBV-C/ 
HGV genotypes depends on their geographical distribution. 
The GB type mainly includes the African isolates with the 
prototype of GBV-C. The HG type consists of the isolates 
from the USA, Europe and Asia. The new type consists of 
the isolates from Asian countries. 
There are two issues that need to be addressed. First, this 
classification needs to be confirmed by studying other parts of 
the viral genome. Studies on HCV genetic heterogeneity have 
shown that nearly all HCV isolates segregated together in the 
same phylogenetic branch [14,15] for all genomic regions 
studied so far (5'-UTR, core, El, and NS5). To be scientifi-
cally certain, we believe that a similar approach, i.e., to con-
firm this phylogenetic relationship with other genomic re-
gions, is important for definitive conclusions. The small 
number of GBV-C/HGV sequences, and the genetic heteroge-
Fig. 4. Schematic representation of the strategy for PCR amplification with nested primer pairs and the RFLP pattern. Comparison of ScrFI 
and BsmFI RFLP pattern of the 5'-UTR PCR products from different genotypes is also given. 
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neity of GBV-C/HGV, makes this a difficult task. However, 
this preliminary data serves as the backbone for further com-
parison. Second, despite the distinct segregation of the GBV-
C/HGV isolates into three separate branches, the diversity of 
isolates from different branches was still in the range of 8.7-
29.1%. Even when the full genome of GBV-C and HGV were 
compared, the diversity was only around 16%. As GBV-C/ 
HGV is phylogenetically close to HCV [5], the order of clas-
sification of HCV genotypes has to be taken into considera-
tion. It appears that the separation of the branches is in the 
order of subtype difference in the HCV classification. Hence, 
we are reluctant to call these three branches as representing 
three major types (including assigning them numerical num-
bers) since this may imply a similar level of diversity as in 
HCV. The exact naming of these genotypes awaits further 
discussion between various research groups for a consensus. 
So far, to identify genotypes of GBV-C/HGV, the determi-
nation of RNA sequence of each isolates was needed. How-
ever, we have developed a simple genotyping method. Using 
two restriction enzymes (ScrFI and BsmFI), which recognize 
genotype-specific site(s) in the product by PCR, three major 
genotypes are able to be identified by RFLP easily. With our 
approach, all 33 isolates will be assigned according to the 
phylogenetic branch. Certainly, this assay will need to be con-
firmed in prospective studies with GBV-C/HGV isolates from 
various geographical locations. If this approach is confirmed 
to be useful in larger studies, this simple method will be useful 
for the epidemiological survey of GBV-C/HGV. It may also 
be useful for studying transmission of this virus in selected 
cases. 
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